Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: According to July PR Patents came out stronger

l2007s,

More than 75 global, market-leading companies from the US, Europe, Japan, Korea, Taiwan and China have licensed the MMP Portfolio(TM) technologies, resulting in over $300 million in licensing revenue. The MMP Portfolio has also been successful in litigation, with eight litigants purchasing licenses

I read more than 80 companies somewhere. I can't remember where--I will have to go back and look it up. GL, ads

Share
New Message
Please login to post a reply